aprepitant stada 80 mg a aprepitant stada 125 mg
stada arzneimittel ag, nemecko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant stada 125 mg
stada arzneimittel ag, nemecko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant stada 80 mg
stada arzneimittel ag, nemecko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant sandoz 80 mg tvrdé kapsuly + aprepitant sandoz 125 mg tvrdé kapsuly
sandoz pharmaceuticals d.d., slovinsko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant teva 80 mg a aprepitant teva 125 mg
teva b.v., holandsko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant teva 80 mg
teva b.v., holandsko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant mylan 125 mg + aprepitant mylan 80 mg
mylan ireland limited, Írsko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant mylan 125 mg
mylan ireland limited, Írsko - aprepitant - 20 - antiemetica, antivertiginosa
aprepitant mylan 80 mg
mylan ireland limited, Írsko - aprepitant - 20 - antiemetica, antivertiginosa
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovírusové infekcie - antivirotiká na systémové použitie - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní protivírusové agentov.